English
This article is from Advanced Biomedical Research , volume 3 . Abstract Background:: End stage renal disease (ESRD) is a condition that inflammation and oxidative stress plays an important role in damaging to tissues, especially, in the vascular system. The effect of omega-3 fatty acids is well-documented in some inflammatory diseases via eicosapentanoic acid and docosahexanoic acid components of fish oil. The aim of this study was to investigate the effects of dietary omega-3 fatty acid supplementation on levels of lipid peroxidation and oxidative sttress in ESRD patients. Materials and Methods:: This randomized controlled double-blind clinical trial consisted of 90 patients on chronic ambulatory peritoneal dialysis (CAPD). One group was treated orally with 3000 mg omega-3, per day for 8 weeks (n = 45) and the other matched group by placebo (n = 45). Serum levels of lipids, iron, ferritin, Protrombin Time, Partial thromboplastin time, superoxide dismutase (SOD), and reduced glutathione (GH) were measured at the beginning and at 8 weeks. Results:: Our results showed that SOD and reduced GH were not significantly changed in omega-3 group where lipid profile showed no significant cha
Sign in with your free account to read, download EPUBs or listen.
Ebook · The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients. · Taheri, Shahram, Keyvandarian, Nooshin, Moeinzadeh, Firouzeh, Mortazavi, Mojgan, Naini, Afsoon Emami · Internet Archive